Interview with Joseph Lam , Managing Director, Beacons Pharmaceuticals
As one of the few surviving Singaporean manufactures, what has been the key to success? Our history spans more than 40 years and our success lies in our ability to…
Address: 2 Second Chin Bee Road Singapore 618769,Singapore
Tel: +65 6265 2336
Web: http://www.beacons.com.sg/
Beacons is Singapore’s largest manufacturer of generic pharmaceuticals, with a track record of success spanning of almost 40 years. The company is one of the leading providers of high quality, fully integrated contract pharmaceutical manufacturing services, it also produces over 200 therapeutics in a variety of dosage forms, sold under the Beacons brand name.
Beacons Pharmaceuticals owns and operates two PIC/S GMP certified manufacturing facilities in Singapore, a pharmacy operation in Malaysia, a JV in Sichuan, China, and owns Beacons Technology Systems, the developer of the innovative SPAH production space technology solution and Beacons SPAH solution.
Gernic drugs and SPAH system
As one of the few surviving Singaporean manufactures, what has been the key to success? Our history spans more than 40 years and our success lies in our ability to…
To cater to Japan and Asia Pacific (JAPAC)’s booming biotech industry, in May 2021 IQVIA expanded its ‘IQVIA Biotech’ brand into the region. Looking ahead to 2022, IQVIA Biotech JAPAC…
Writing in the December edition of DIA’s Global Forum magazine, Agnes Ho, Cindy Zen, and Tan Kwee Lan of Boehringer Ingelheim give an overview of the current regulatory framework for…
Asia has experienced a biotech boom in the past five years. In 2020, almost 50 percent of the region’s clinical trials were led by biotechs and by 2025, biotech-led clinical…
Angeline Ho gives an overview of the patient advocacy landscape in Asia-Pacific, why an Asian model of patient engagement – distinct from those in Europe and the US – needs…
The Asia-Pacific (APAC) region is home to around 1.44 billion people, over 60 percent of the world’s population, and a vast diversity of cultures, infrastructures, and economic development. Managing a…
Ashish Mahajan, Partner in Deloitte’s Life Sciences and Healthcare Consulting Practice in Southeast Asia, outlines some of the key trends playing out in the region, the extent to which the…
Professor Subra Suresh, president of Nanyang Technological University (NTU) and former director of the US National Science Foundation, explains how the university has managed to consistently be among the top…
Marco Lee, APAC head for medical device firm Avanos explains how the company’s products are catered to patient needs in the region and talks through key growth drivers, the impact…
AstraZeneca (AZ)’s country president for Singapore, Vinod Narayanan, outlines the challenges of taking the reins at an affiliate against the backdrop of a pandemic and how the Anglo-Swedish company’s quest…
One of the main supporting pillars of Singapore’s pharmaceutical industry is its magnificent manufacturing base. Not only does the city-state rank as one of the few countries on the planet…
Cindy Engelbart, director of mid-sized logistics player Agility’s life science operations in APAC, highlights some of the key trends in global logistics that have emerged from the COVID-19 pandemic, how…
In 2020, the FDA granted its first approval to a comprehensive liquid biopsy, potentially representing a paradigm shift towards using liquid biopsies upfront as an easier, safer, faster, and more…
See our Cookie Privacy Policy Here